Tag: Share sale

Browse our exclusive articles!

OpenAI in Talks to Sell Shares, Valuation Reaches $86B

OpenAI in talks to sell shares, aiming for an $86B valuation. If successful, it would become one of the most valuable firms globally. Find out more.

OpenAI’s $90 Billion Valuation on Verge amidst Investor Interest and Major Updates

OpenAI, the AI company valued at $90 billion, is in discussions for a share sale, solidifying its position in AI. Exciting updates for developers coming soon.

Investor Frenzy Over Short-Term AI Gains in Silicon Valley is Too Much, Says OpenAI CEO Sam Altman

OpenAI CEO Sam Altman warns Silicon Valley investors that there is too much hype surrounding the short-term value of AI technology. Although the long-term potential is underhyped, Altman states that much work needs to be done before they can start the model. Despite this, the company recently raised $495 million in funding and is valued at $27-29 billion.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img